Core Insights - The company has confirmed its financial guidance for 2025, narrowing organic revenue growth expectations to a range of -2% to +2% [8][12] - The Hearing division is expected to contribute organic revenue growth of 5% to 9%, but due to lower market growth assumptions, it is now anticipated to grow at the lower end of that range [5][4] - The Enterprise division is facing challenges due to market uncertainty, with expected organic revenue growth of -8% to 0% [6] - The Gaming division is also impacted by trade environment changes, with organic revenue growth now expected in the upper half of the range of -6% to +2% [7] Financial Performance - Group reported EBITA increased by 46% to DKK 546 million, with an EBITA margin of 13% [8] - Free cash flow excluding M&A was DKK 353 million, reflecting a positive earnings profile and working capital impact [8] - The Hearing division achieved 8% organic revenue growth, while the Enterprise division saw a decline of -7% [8][10] Market Conditions - The hearing aid market is projected to grow at 4-6% in volumes, driven by favorable demographic trends, but is expected to grow slower than its structural trend in 2025 [4] - The company is actively diversifying its manufacturing footprint and implementing price adjustments to mitigate impacts from the changing trade environment [6][9] - The overall impact of tariffs is expected to reduce the group EBITA margin by approximately -1% in 2025 [10]

Core Insights - GN Store Nord has adjusted its financial guidance for 2025, now expecting organic revenue growth of -3% to +3%, an EBITA margin of 11% to 13%, and free cash flow excluding M&A to remain around DKK 800 million [2][6]. Financial Guidance for 2025 - The company anticipates organic revenue growth excluding wind to be down from a prior estimate of 3% to 7% to a new range of -3% to +3% [2]. - EBITA margin guidance has been revised down from 12% to 14% to a new range of 11% to 13% [2]. - Free cash flow excluding M&A is confirmed to be approximately DKK 800 million, unchanged from previous guidance [2]. Revenue Assumptions by Division Hearing Division - GN expects the hearing aid market to grow at historical rates, projecting a market volume growth of 4-6% and a market value growth of 3-5% in 2025 [3]. - The division aims for organic revenue growth of 5% to 9%, supported by the launch of ReSound Vivia and ReSound Savi [3]. Enterprise Division - The current market environment has led to uncertainty, causing companies to postpone IT projects, which negatively impacts the addressable market [4]. - The division anticipates organic revenue growth of -8% to 0% due to these challenges and prioritization of product variants shipped to the U.S. [4]. Gaming Division - The gaming gear market is expected to be negatively impacted by a decline in consumer sentiment in the U.S. and global economic uncertainty [5]. - The division projects organic revenue growth of -6% to +2%, excluding the impact from the wind-down of certain product lines [5]. Q1 2025 Financial Performance - GN reported a group revenue of DKK 3,986 million for Q1 2025, reflecting a 7% decline compared to Q1 2024 [6]. - The Hearing division experienced a -1% organic revenue growth, while the Enterprise division faced a -9% decline [6]. - The Gaming division reported an 11% organic revenue growth, excluding the impact from the wind-down of certain product lines [6]. - Group EBITA was DKK 300 million, with an EBITA margin of 8%, indicating a significant decline from previous periods [6]. - Free cash flow excluding M&A was reported at DKK -395 million, influenced by seasonality and higher interest payments [6]. Management Commentary - The CEO expressed confidence in the underlying strength of the business despite short-term challenges and emphasized the successful launch of ReSound Vivia [6][8]. - The company is taking significant actions to mitigate the impact of tariffs, including diversifying its manufacturing footprint and implementing price increases in the U.S. [6][9].

Core Viewpoint - GN is taking proactive measures to mitigate the negative impacts of increased tariffs on its EBITA margin and mid-term earnings growth, aiming to counteract the uncertainty in the market environment [1][2][3]. Financial Guidance for 2025 - GN's updated financial guidance for 2025 indicates an organic revenue growth expectation of -3% to +3%, with an EBITA margin projected to be 11% to 13%, and confirmed free cash flow of approximately 800 million DKK [4]. Hearing Division - The hearing aid market is expected to grow at a rate of 4-6% in volume, with a slight decline in average selling price (ASP) of -1%, leading to an overall market value growth of 3-5%. GN anticipates organic revenue growth of 5% to 9% in this division [6]. Enterprise Division - The Enterprise division is facing a negative impact on revenue growth, projected at -8% to 0%, due to postponed IT projects and prioritization of product variants shipped to the U.S. until supply chain diversification is completed [7]. Gaming Division - The Gaming division expects organic revenue growth of -6% to +2%, influenced by a decline in consumer sentiment and prioritization of product variants for U.S. customers. The company is accelerating its manufacturing diversification to reduce reliance on China by the end of 2025 [8][9].